Literature DB >> 33360365

Development and Open Trial of a Technology-Enhanced Family Intervention for Adolescents at Risk for Mood Disorders.

David J Miklowitz1, Marc J Weintraub2, Filippo Posta3, Patricia D Walshaw2, Samantha J Frey2, Georga M Morgan-Fleming2, Catherine A Wilkerson2, Danielle M Denenny2, Armen A Arevian2.   

Abstract

AIM: Integrating psychosocial interventions with mobile apps may increase treatment engagement among adolescents. We examined the user experience, uptake, and clinical effects of a mobile-enhanced family-focused therapy (FFT) among adolescents at risk for mood disorders.
METHOD: We created a mobile app containing 12 lesson plans corresponding to content of weekly FFT sessions, with modules concerning mood management, family communication and problem-solving. We pilot tested the app in an open trial of FFT (12 sessions in 18 weeks) for adolescents who had active depressive or hypomanic symptoms, a parent with mood disorder, and at least one parent who expressed high levels of criticism. Teens and parents made daily and weekly ratings of youths' moods, amount of parent/offspring criticism, and practice of FFT psychoeducational, communication or problem-solving skills. Independent evaluators interviewed adolescents at baseline and every 9 weeks over 27 weeks to measure symptom trajectories.
RESULTS: Participants were adolescents (n=22; mean age 15.4 ± 1.8 years; 45.5% female) and their 34 parents. Completion of requested app assessment and skill practices averaged 46%-65% among adolescents and parents over 18 weeks of treatment. Adolescents showed significant improvement in clinician-rated depression scores over 27 weeks (Cohen's d=1.58, 95% CI, 0.83 to 2.32) and reported reductions in the amount of perceived criticism expressed by parents. LIMITATIONS: The uncontrolled design limits inferences about whether the mobile app augmented the effects of FFT on moods or family relationships.
CONCLUSIONS: Mobile applications may enhance users' responses to family therapy and provide clinicians with information regarding clinical status. Clinicaltrials.gov NCT03913013.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Digital mental health; bipolar disorder; early intervention; expressed emotion; mobile apps

Mesh:

Year:  2020        PMID: 33360365      PMCID: PMC8068558          DOI: 10.1016/j.jad.2020.12.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  36 in total

Review 1.  How is affective instability defined and measured? A systematic review.

Authors:  S Marwaha; Z He; M Broome; S P Singh; J Scott; J Eyden; D Wolke
Journal:  Psychol Med       Date:  2013-09-27       Impact factor: 7.723

Review 2.  Family-Focused Therapy for Bipolar Disorder: Reflections on 30 Years of Research.

Authors:  David J Miklowitz; Bowen Chung
Journal:  Fam Process       Date:  2016-07-29

3.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

4.  Toward the Definition of a Bipolar Prodrome: Dimensional Predictors of Bipolar Spectrum Disorders in At-Risk Youths.

Authors:  Danella M Hafeman; John Merranko; David Axelson; Benjamin I Goldstein; Tina Goldstein; Kelly Monk; Mary Beth Hickey; Dara Sakolsky; Rasim Diler; Satish Iyengar; David Brent; David Kupfer; Boris Birmaher
Journal:  Am J Psychiatry       Date:  2016-02-19       Impact factor: 18.112

5.  Bipolar disorder and family communication: effects of a psychoeducational treatment program.

Authors:  T L Simoneau; D J Miklowitz; J A Richards; R Saleem; E L George
Journal:  J Abnorm Psychol       Date:  1999-11

Review 6.  Pediatric bipolar disorder: evidence for prodromal states and early markers.

Authors:  Joan L Luby; Neha Navsaria
Journal:  J Child Psychol Psychiatry       Date:  2010-01-18       Impact factor: 8.982

7.  Participatory epidemiology: use of mobile phones for community-based health reporting.

Authors:  Clark C Freifeld; Rumi Chunara; Sumiko R Mekaru; Emily H Chan; Taha Kass-Hout; Anahi Ayala Iacucci; John S Brownstein
Journal:  PLoS Med       Date:  2010-12-07       Impact factor: 11.069

8.  Pharmacotherapy and family-focused treatment for adolescents with bipolar I and II disorders: a 2-year randomized trial.

Authors:  David J Miklowitz; Christopher D Schneck; Elizabeth L George; Dawn O Taylor; Catherine A Sugar; Boris Birmaher; Robert A Kowatch; Melissa P DelBello; David A Axelson
Journal:  Am J Psychiatry       Date:  2014-06       Impact factor: 18.112

9.  Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder: A Randomized Clinical Trial.

Authors:  David J Miklowitz; Christopher D Schneck; Patricia D Walshaw; Manpreet K Singh; Aimee E Sullivan; Robert L Suddath; Marcy Forgey Borlik; Catherine A Sugar; Kiki D Chang
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

10.  Clinical state tracking in serious mental illness through computational analysis of speech.

Authors:  Armen C Arevian; Daniel Bone; Nikolaos Malandrakis; Victor R Martinez; Kenneth B Wells; David J Miklowitz; Shrikanth Narayanan
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

View more
  3 in total

Review 1.  Research Status in Clinical Practice Regarding Pediatric and Adolescent Bipolar Disorders.

Authors:  Lu Liu; Ming Meng; Xiaotong Zhu; Gang Zhu
Journal:  Front Psychiatry       Date:  2022-05-27       Impact factor: 5.435

2.  Therapeutic alliance in family therapy and clinical outcomes among adolescents at risk for mood disorders.

Authors:  Nicole R Wong; Kayla E Carta; Marc J Weintraub; David J Miklowitz
Journal:  J Affect Disord       Date:  2021-12-22       Impact factor: 4.839

3.  Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial.

Authors:  David J Miklowitz; Jean M Addington; Mary P O'Brien; Danielle M Denenny; Marc J Weintraub; Jamie L Zinberg; Daniel H Mathalon; Barbara A Cornblatt; Michelle S Friedman-Yakoobian; William S Stone; Kristin S Cadenhead; Scott W Woods; Catherine A Sugar; Tyrone D Cannon; Carrie E Bearden
Journal:  Early Interv Psychiatry       Date:  2021-08-23       Impact factor: 2.721

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.